Insights into the Global Mental Health Screening Market: Trends and Opportunities

https://www.marketsandmarkets.com/Market-Reports/mental-health-screening-market-198516770.html

The Mental Health Screening market is projected to reach USD 1.8 billion by 2029 from USD 0.9 billion in 2023, at a CAGR 12.2% from 2023 to 2029. Mental health screening refers to the process of assessing an individual’s mental health status to identify potential signs or symptoms of mental health conditions. It is a preliminary step in recognizing and addressing mental health concerns early on. The goal of mental health screening is to identify individuals who may be at risk of or experiencing mental health issues so that appropriate interventions, support, or further assessments can be provided. The growth of this market is driven by the rising awareness of mental health issues, growing geriatric population and subsequent increase in the prevalence of mental disorders, and technological advancements. However, the concerns regarding accuracy and validity of the screening platforms inhibits the market growth.

The Mental Health Screening market is competitive. The major players operating in this market are Proem Behavioral Health (US), SonderMind Inc. (US), Riverside Community Care (US), Headspace Health (US), Quartet Health, Inc. (US), Canary Speech, Inc. (US), Sonde Health, Inc. (US), Koninklijke Philips N.V. (Netherlands), Alphabet Inc. (Fitbit) (US), ResMed (US), Apple Inc. (US), Wellin5 USA Inc. (Canada), Clarigent Health (US), Woebot Labs Inc. (US), and Aiberry (US).